March Biosciences

Developer of CAR-T cell therapies for malignancies

placeHouston, Texas, United States calendar_todayFounded 2022 language march.bio

Social engagement

Social engagement: 4.3K social following, 8 posts in the last 12 months — below the industry typical range.

Investor mix

13 investors on record; lead investors include 4Bio Capital, Mission BioCapital, Cancer Focus Fund.

Investor typeCountShare
Venture capital754%
Angel & family office18%
Accelerator & incubator18%
Other / undisclosed431%

Hiring activity

Hires occasionally

1 role tracked across 1 of the last 12 months

17 Dec 2025 · Clinical Sample & Logistics Specialist · Houston, Texas

Based on job postings tracked across public sources.

Recent activity

3 Dec 2025
Leadership hire
Chief Business Officer
11 Nov 2025
Milestone
regulatory
11 Oct 2025
Leadership hire
CICET (Columbia Initiative in Cell Engineering and Therapy)
Coming soon